Invention Grant
- Patent Title: Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
- Patent Title (中): 咪唑并吡嗪类化合物可用于治疗退行性和炎性疾病
-
Application No.: US11803015Application Date: 2007-05-11
-
Publication No.: US07893058B2Publication Date: 2011-02-22
- Inventor: Martin James Inglis Andrews , Paul Edwards , Philip Huxley , Wolfgang Schmidt , Veronique Birault , Mark Stuart Chambers , Clifford John Harris , Angus MacLeod , Kim Louise Hirst , Juha Andrew Clase , Gregory Bar
- Applicant: Martin James Inglis Andrews , Paul Edwards , Philip Huxley , Wolfgang Schmidt , Veronique Birault , Mark Stuart Chambers , Clifford John Harris , Angus MacLeod , Kim Louise Hirst , Juha Andrew Clase , Gregory Bar
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/4985
Abstract:
Novel imidazo[1,2-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.
Public/Granted literature
- US20070281943A1 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases Public/Granted day:2007-12-06
Information query
